We performed an in vitro CTL killing assay using CD4 T cells with either high PD-1 (from PBS-treated tumor-bearing mice) or low PD-1 (from methionine-treated tumor-bearing mice) expression levels (Fig. 2d). Here, PDCD1 is linked to neoplasm.